MAPT and Alzheimer disease: We also found that p-tau181, p-tau217, and p-tau231 were associated with Aβ pathology in the brain, and p-tau217 was associated with tau pathology in the brain, which is consistent with previous results [5, 42, 43], suggests that p-tau has a good predictive effect on AD-related pathology.